World’s Smallest Pacemaker Can Help Stop Surgical Complications

The University of Michigan recently implanted its first Micra leadless pacemaker directly into a patient’s heart, eliminating some of the issues associated with older devices.

7:00 AM

Author | Shantell M. Kirkendoll

Heart patients in the U.S. are beginning to take advantage of a miniature pacemaker that stimulates a regular heart rhythm without the connecting leads or wires of a conventional pacemaker.

Electrophysiologist Ryan Cunnane, M.D., recently implanted the new leadless Micra Transcatheter Pacing System at the University of Michigan Frankel Cardiovascular Center — a first-of-its-kind procedure for the university that comes as a new generation of miniaturized medical devices is being developed.

SEE ALSO: A Tough Surgery with a 'Transformative Impact' for CTEPH

Medtronic's Micra is one-tenth the size of a traditional pacemaker, or about the size of a large vitamin. The pacemaker is revolutionary not only for its measurements, but also because it is placed inside the heart.

"There's no incision in the chest, and no leads, which means none of the larger device-related complications that go with that," says Cunnane.

How Micra works

The 1-inch device, the world's smallest pacemaker, is implanted directly onto the inside heart wall. Flexible prongs hold it in place. Electrical impulses are then generated to regulate heartbeats in the same fashion as traditional single-chamber pacemakers.

Traditional pacemakers sit in a "pocket" just under the skin below the collarbone with one or more electrodes running directly into the heart. Though complications of this implantation are uncommon, the electrodes can break or become dislodged or infected, requiring subsequent procedures such as lead extractions.

Micra inserts through a vein in the patient's groin and then affixes directly to the heart. No scar or visible bump in the chest results, as from conventional pacemakers.

The leadless device also eliminates potential medical complications arising from a chest incision and from wires running from a conventional pacemaker into the heart.

A clinical trial involving 719 patients implanted with Micra found 98 percent had adequate heart pacing six months after implantation, and complications occurred in less than 7 percent of trial participants, according to the Food and Drug Administration, which approved the device in April.

Who needs a pacemaker?

Cardiac pacemakers treat a too-slow heart rate called bradycardia.

The device stimulates the heart to a normal rhythm so patients feel well and avoid dizziness and fainting.

SEE ALSO: Artificial Placenta Holds Promise for Extremely Premature Infants

Some limitations in how it performs may hinder its use. Micra regulates activity of the lower chambers of the heart from the right side only. Some patients may need more complex support from dual- chamber (which work in both the upper and lower chambers) or biventricular (working in both lower chambers) systems.

Micra is not suggested for patients who have implanted devices that would interfere with the pacemaker, who are severely obese or who have complex congenital heart disease, making it difficult to access the right lower chamber (right ventricle) of the heart.

It also should not be used in patients whose veins cannot accommodate the 7.8 millimeter introducer sheath or pacemaker implant.

Micra has a battery life of about 12 years, which is about the same as traditional pacemakers.

When the battery life expires, Micra can be retrieved. What's more likely is that doctors will leave the device in the heart but permanently turn it off and implant another one, Cunnane explains.

Micra is a result of a 10-year program at Medtronic called "deep miniaturization." The goal a decade ago was to shrink medical devices by up to 90 percent.

Medtronic scientists, engineers and designers succeeded by figuring out how to make a new generation of tiny devices that use a fraction of the energy they once did, the company says.

Micra is one of the first of those new devices to reach patients.


More Articles About: Body Work Cardiac Surgery Cardiovascular: Treatment & Surgery
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories
Health Lab
A Tough Surgery with a ‘Transformative Impact’ for CTEPH
A U-M cardiac surgeon speaks about a rare form of blood clots called CTEPH. When medication fails, a complex surgery called PTE has shown successful outcomes.
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
Blurred image of health care professionals in blue scrubs pushing a gurney down a hallway
Health Lab
Primary care scarcity linked to more surgical emergencies, problems
Patients living in areas with the worst shortages of primary care providers are more likely to have emergency surgery, surgical complications and hospital readmissions.
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
News Release
Statewide cardiovascular consortium, hosted at Michigan Medicine, receives national award for patient safety, quality efforts
A collaborative partnership dedicated to improving statewide cardiovascular care and outcomes — hosted at Michigan Medicine — received national recognition for efforts in patient safety and quality. BMC2 received the award for its significant improvements in the documentation of radiation use, a decrease in high-dose radiation exposure and reduction in opioid prescribing rates for patients.
Health Lab
Teen turns EKG heart readings into art
Teenage heart patient transforms EKG paper into art creations, sold as notecards to support research at University of Michigan Health C.S. Mott Children’s Hospital